Enhancement of anti-neoplastic drug efficacy using EGF

Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 2, 514 19, A61K 3324, A61K 3100

Patent

active

052523420

ABSTRACT:
The present invention comprises a method of sensitizing cancer cells to cisplatin or other cytotoxic agents and augmenting the sensitivity of cancer cells to these cytotoxic agents. The invention provides a method to treat cancer and other cell proliferative diseases by the administration of a sensitizing agent prior to or concurrently with the administration of a cytotoxic agent.

REFERENCES:
patent: 4571336 (1986-02-01), Houck et al.
patent: 4863902 (1989-09-01), Harunbu et al.
patent: 4925922 (1980-05-01), Byers et al.
patent: 4959353 (1990-09-01), Brown et al.
patent: 4962091 (1990-10-01), Eppstein et al.
C.A. vol. 106 (21)-169447(u).
C.A. vol. 109 (25)-222460(h).
C.A. vol. 110 (9)-69068(k).
C.A. vol. 113 (21)-185362(n).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enhancement of anti-neoplastic drug efficacy using EGF does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancement of anti-neoplastic drug efficacy using EGF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of anti-neoplastic drug efficacy using EGF will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1902860

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.